CAS: 14649-03-7; (S)-1-Phenylethylisocyanate

该化合物是一种有机化合物,其特征是附于甲基苯基甲酸酯的异丙氰酸酯功能组(-N=C=O),该化合物一般没有色状,可粉黄,具有独特的气味,以其反应性为名,特别是核生殖性反应,使其在有机合成和生产各种异氰酸衍生物中具有价值;异丙酸组的存在允许形成尿素和氨基甲酸酯,这对制药和农用化学品十分重要;(-)-甲基苯基异丙酸酯具有潜在的毒性和刺激性,需要小心处理和储存;有机溶剂溶性,但水溶性有限;与许多异丙酸盐一样,接触甲醚会给健康带来风险,包括呼吸刺激和敏化;因此,在实验室或工业环境中与该化合物合作时,应采取适当的安全措施.

结构式图片

相似化合物

33375-06-3 3173-56-6 3634-83-1

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

CAS号2627-86-3 (S)-(-)-α-甲基苄胺 | CAS号503-38-8 氯甲酸三氯甲酯 | CAS号75-44-5 光气 | CAS号2627-86-3 (S)-(-)-α-甲基苄胺 | CAS号33290-12-9 (S)-1-苯基乙基氨基甲酸乙酯 | CAS号115914-08-4 (S)-()-N-烯丙基-α-甲基苄胺 | CAS号88235-78-3 5-hydroxyimino-... | CAS号88235-82-9 5-imino-3,4,4-t...

合成工艺路线路线简述

    2-苯基丙酸置于羟胺,N,N-二异丙基乙胺,对硝基苯磺酰氯体系中,用 四氢呋喃,水,乙腈 用作溶剂,化学反应 17.0H,反应生成Alpha-甲基异氰酸苄酯
    参考文献:N-甲基咪唑催化异羟肟酸通过洛森重排合成氨基甲酸酯
    标题:N-甲基咪唑催化异羟肟酸通过洛森重排合成氨基甲酸酯
    摘要:报道了一种有效的,一锅法,N-甲基咪唑 (Nmi) 通过 Lossen 重排加速合成芳香族和脂肪族氨基甲酸酯的方法.Nmi 是将异氰酸酯中间体转化为氨基甲酸酯的催化剂.此外,芳基磺酰氯与 Nmi 组合的效用最大限度地减少了在序列过程中经常观测到的异羟肟酸酯-异氰酸酯二聚体的形成.在目前的条件下,降低温度也是可能的,从而实现温和的协议.
    Doi:10.1021/ol303424B

    海关参考信息

    专利信息


    专利号:US-5840915-A
    优先权日:1990-01-22
    标题:Process for the enatioselective synthesis of intermediates used
    发明人:LEE THOMAS BING KIN; WONG GEORGE SEUNG-KIT
    权利人:HOECHST MARION ROUSSEL INC
    摘要:A process for the stereoselective synthesis of [R]- and [S]-2,3-dihydro-1,3-dimethyl-2-oxo-1H-indole-3-acetonitriles comprises reacting racemic and 5-alkoxy-substituted (+/-)-1,3-dimethyloxindoles with a halogenated acetonitrile in the presence of a substituted N-benzyl cinchoninium, quinidinium, cinchonidinium, or quininium catalyst. The resulting alkylated oxindoles can be converted to primary amines by catalytic reduction in the presence of hydrogen gas. One of the primary amines, such as enantiomers of 3-(2-aminoethyl)-1,3-dihydro-1,3-dimethyl-5-methoxy-2H-indol-2-one, can be enriched by contact with a chiral tartaric acid in an amount sufficient to preferentially precipitate a salt of the chiral acid and one of the enantiomers. The product can be used in the synthesis of stereospecific forms of physostigmine and related compounds having pharmaceutical activity.

    专利号:US-5274117-A
    优先权日:1990-01-22
    标 题:Process for the enantioselective synthesis of intermediates used in the preparation of physostigmine
    发明人:LEE THOMAS BING KIN DR; WONG GEORGE S K
    权利人:HOECHST ROUSSEL PHARMA
    摘要:A process for the stereoselective synthesis of [R]- and [S]-2,3-dihydro-1,3-dimethyl-2-oxo-1H-indole-3-acetonitriles comprises reacting racemic and 5-alkoxy-substituted (+/-)-1,3-dimethyloxindoles with a halogenated acetonitrile in the presence of a substituted N-benzyl cinchoninium, quinidinium, cinchonidinium, or quininium catalyst. The resulting alkylated oxindoles can be converted to primary amines by catalytic reduction in the presence of hydrogen gas. One of the primary amines, such as enantiomers of 3-(2-aminoethyl)-1,3-dihydro-1,3-dimethyl-5-methoxy-2H-indol-2-one, can be enriched by contact with a chiral tartaric acid in an amount sufficient to preferentially precipitate a salt of the chiral acid and one of the enantiomers. The product can be used in the synthesis of stereospecific forms of physostigmine and related compounds having pharmaceutical activity.

    专利号:EP-0438796-B1
    优先权日:1990-01-22
    标题:Process for the enantioselection synthesis of alkylated oxindoles used as intermediates in the preparation of physostigmine
    发明人:LEE THOMAS BING KIN DR; WONG GEORGE S K
    权利人:HOECHST MARION ROUSSEL INC
    摘要:A process for the stereoselective synthesis of [R]- and [S]-2,3-dihydro-1,3-dimethyl-2-oxo-1H-indole-3-acetonitriles comprises reacting racemic and 5-alkoxy-substituted (+/-)-1,3-dimethyloxindoles with a halogenated acetonitrile in the presence of a substituted N-benzyl cinchoninium, quinidinium, cinchonidinium, or quininium catalyst. The resulting alkylated oxindoles can be converted to primary amines by catalytic reduction in the presence of hydrogen gas. One of the primary amines, such as enantiomers of 3-(2-aminoethyl)-1,3-dihydro-1,3-dimethyl-5-methoxy-2H-indol-2-one, can be enriched by contact with a chiral tartaric acid in an amount sufficient to preferentially precipitate a salt of the chiral acid and one of the enantiomers. The product can be used in the synthesis of stereospecific forms of physostigmine and related compounds having pharmaceutical activity.

    专利号:US-4201869-A
    优先权日:1970-12-21
    标 题:Intermediates for steroid total synthesis process utilizing asymmetric induction
    发明人:COHEN NOAL; SAUCY GABRIEL
    权利人:HOFFMANN LA ROCHE
    摘要:A multi-step, stereospecific total synthesis of steroids is disclosed. The starting materials for this process are the relatively inexpensive and readily available m-alkoxy acetophenones. The process is suitable for the preparation of racemic or optically active, medicinally valuable steroids, particularly A-ring aromatic steroids. This process features an early optical resolution and a unique asymmetric induction which insures the correct stereochemistry of the final steroidal product.

    专利号:US-4092483-A
    优先权日:1973-10-16
    标题 :Intermediates for steroid total synthesis process utilizing asymmetric induction
    发明人:COHEN NOAL; SAUCY GABRIEL
    权利人:HOFFMANN LA ROCHE
    摘要:A multi-step, stereospecific total synthesis of steroids is disclosed. The starting materials for this process are the relatively inexpensive and readily available m-alkoxy acetophenones. The process is suitable for the preparation of racemic or optically active, medicinally valuable steroids, particularly A-ring aromatic steroids. This process features an early optical resolution and a unique asymmetric induction which insures the correct stereochemistry of the final steroidal product.

    专利号:US-4102925-A
    优先权日:1970-12-21
    标题:Steroid total synthesis process utilizing asymmetric induction
    发明人:COHEN NOAL; SAUCY GABRIEL
    权利人:HOFFMANN LA ROCHE
    摘要:A multi-step, stereospecific total synthesis of steroids is disclosed. The starting materials for this process are the relatively inexpensive and readily available m-alkoxy acetophenones. The process is suitable for the preparation of racemic or optically active, medicinally valuable steroids, particularly A-ring aromatic steroids. This process features an early optical resolution and a unique asymmetric induction which insures the correct stereochemistry of the final steroidal product.
    嘉兴市鑫瑞医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xrpharm.com
    企业联系电话:0573-82750556👤
    📞嘉兴市鑫瑞医药科技有限公司 ⚠️参考联系方式
    联系人:沈先生
    电话:0573-82750556
    手机:18967362650
    传真:0573-82750556
    邮箱:sales@xrpharm.com
    通信地址: 浙江省嘉兴市南湖区勤俭路313号
    邮编: 314000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省嘉兴市南湖区勤俭路313号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Miyagishi, H. V.; Nagaki, A., Science of Synthesis: Knowledge Updates, (2024) 1, 206.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知